X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALEMBIC LTD AJANTA PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 19.8 75.2 26.3% View Chart
P/BV x 8.6 2.8 306.2% View Chart
Dividend Yield % 0.7 0.4 174.7%  

Financials

 AJANTA PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
ALEMBIC LTD
Mar-16
AJANTA PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,72053 3,257.6%   
Low Rs1,10329 3,764.5%   
Sales per share (Unadj.) Rs194.64.7 4,123.3%  
Earnings per share (Unadj.) Rs45.28.8 515.4%  
Cash flow per share (Unadj.) Rs50.39.0 558.6%  
Dividends per share (Unadj.) Rs8.000.15 5,333.3%  
Dividend yield (eoy) %0.60.4 155.1%  
Book value per share (Unadj.) Rs132.027.7 476.2%  
Shares outstanding (eoy) m88.77267.03 33.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.38.7 83.4%   
Avg P/E ratio x31.24.7 667.1%  
P/CF ratio (eoy) x28.14.6 615.5%  
Price / Book Value ratio x10.71.5 722.1%  
Dividend payout %17.71.7 1,034.8%   
Avg Mkt Cap Rs m125,29910,962 1,143.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,570238 1,079.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m17,2751,260 1,370.7%  
Other income Rs m166264 63.0%   
Total revenues Rs m17,4421,524 1,144.4%   
Gross profit Rs m5,80783 7,013.5%  
Depreciation Rs m45161 733.9%   
Interest Rs m490 16,300.0%   
Profit before tax Rs m5,474285 1,921.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m1,4606 23,932.8%   
Profit after tax Rs m4,0142,343 171.3%  
Gross profit margin %33.66.6 511.7%  
Effective tax rate %26.72.1 1,245.6%   
Net profit margin %23.2185.9 12.5%  
BALANCE SHEET DATA
Current assets Rs m7,6391,689 452.3%   
Current liabilities Rs m2,715486 558.4%   
Net working cap to sales %28.595.4 29.9%  
Current ratio x2.83.5 81.0%  
Inventory Days Days43217 19.9%  
Debtors Days Days7981 97.1%  
Net fixed assets Rs m6,9141,624 425.7%   
Share capital Rs m177534 33.1%   
"Free" reserves Rs m11,4425,960 192.0%   
Net worth Rs m11,7217,404 158.3%   
Long term debt Rs m149104 142.6%   
Total assets Rs m14,8148,010 184.9%  
Interest coverage x112.9950.7 11.9%   
Debt to equity ratio x00 90.1%  
Sales to assets ratio x1.20.2 741.2%   
Return on assets %27.429.3 93.8%  
Return on equity %34.231.6 108.2%  
Return on capital %46.531.3 148.7%  
Exports to sales %55.12.9 1,873.4%   
Imports to sales %6.028.9 20.8%   
Exports (fob) Rs m9,52737 25,679.5%   
Imports (cif) Rs m1,038364 285.3%   
Fx inflow Rs m10,42237 28,091.1%   
Fx outflow Rs m1,678365 459.9%   
Net fx Rs m8,744-328 -2,667.0%   
CASH FLOW
From Operations Rs m3,264346 944.4%  
From Investments Rs m-2,093-48 4,396.8%  
From Financial Activity Rs m-1,186-301 393.9%  
Net Cashflow Rs m-15-3 493.3%  

Share Holding

Indian Promoters % 73.8 64.0 115.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 0.2 775.0%  
FIIs % 7.6 9.7 78.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 26.1 65.1%  
Shareholders   20,968 54,701 38.3%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS